These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35944097)

  • 1. Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1.
    Magalhães RSS; Boechat FC; Brasil AA; Neto JRM; Ribeiro GD; Paranhos LH; Neves de Souza N; Vieira T; Outeiro TF; Neves BC; Eleutherio ECA
    J Cell Biochem; 2022 Nov; 123(11):1808-1816. PubMed ID: 35944097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth and signalling defects of the ggs1 (fdp1/byp1) deletion mutant on glucose are suppressed by a deletion of the gene encoding hexokinase PII.
    Hohmann S; Neves MJ; de Koning W; Alijo R; Ramos J; Thevelein JM
    Curr Genet; 1993; 23(4):281-9. PubMed ID: 8467527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection.
    Tan VP; Miyamoto S
    Autophagy; 2015; 11(6):963-4. PubMed ID: 26075878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
    Wolf A; Agnihotri S; Munoz D; Guha A
    Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel alleles of yeast hexokinase PII with distinct effects on catalytic activity and catabolite repression of SUC2.
    Hohmann S; Winderickx J; de Winde JH; Valckx D; Cobbaert P; Luyten K; de Meirsman C; Ramos J; Thevelein JM
    Microbiology (Reading); 1999 Mar; 145 ( Pt 3)():703-714. PubMed ID: 10217505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trehalose-6-phosphate, a new regulator of yeast glycolysis that inhibits hexokinases.
    Blázquez MA; Lagunas R; Gancedo C; Gancedo JM
    FEBS Lett; 1993 Aug; 329(1-2):51-4. PubMed ID: 8354408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling of the glucose growth defect and the deregulation of glycolysis in Saccharomyces cerevisiae Tps1 mutants expressing trehalose-6-phosphate-insensitive hexokinase from Schizosaccharomyces pombe.
    Bonini BM; Van Dijck P; Thevelein JM
    Biochim Biophys Acta; 2003 Sep; 1606(1-3):83-93. PubMed ID: 14507429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
    Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
    BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for trehalose-6-phosphate-dependent and -independent mechanisms in the control of sugar influx into yeast glycolysis.
    Hohmann S; Bell W; Neves MJ; Valckx D; Thevelein JM
    Mol Microbiol; 1996 Jun; 20(5):981-91. PubMed ID: 8809751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-glucose overflow metabolism in an evolutionary engineered high-performance D-xylose consuming Saccharomyces cerevisiae strain.
    Nijland JG; Shin HY; Dore E; Rudinatha D; de Waal PP; Driessen AJM
    FEMS Yeast Res; 2021 Jan; 21(1):. PubMed ID: 33232441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Hexokinases in Epigenetic Regulation: Altered Hexokinase Expression and Chromatin Stability in Yeast.
    Karri S; Dickinson Q; Jia J; Gan H; Wang Z; Deng Y; Yu C
    Res Sq; 2024 Jan; ():. PubMed ID: 38352584
    [No Abstract]   [Full Text] [Related]  

  • 12. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
    Xu S; Herschman HR
    Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing course: Glucose starvation drives nuclear accumulation of Hexokinase 2 in S. cerevisiae.
    Lesko MA; Chandrashekarappa DG; Jordahl EM; Oppenheimer KG; Bowman RW; Shang C; Durrant JD; Schmidt MC; O'Donnell AF
    PLoS Genet; 2023 May; 19(5):e1010745. PubMed ID: 37196001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.
    Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W
    Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of ethanolic fermentation in permeabilized spheroplasts of wild-type and trehalose-6-phosphate synthase mutants of the yeast Saccharomyces cerevisiae.
    Noubhani A; Bunoust O; Rigoulet M; Thevelein JM
    Eur J Biochem; 2000 Jul; 267(14):4566-76. PubMed ID: 10880982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.
    Wolf A; Agnihotri S; Micallef J; Mukherjee J; Sabha N; Cairns R; Hawkins C; Guha A
    J Exp Med; 2011 Feb; 208(2):313-26. PubMed ID: 21242296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
    Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
    Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
    Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
    Cancer Metab; 2018; 6():7. PubMed ID: 29988332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways.
    Bao C; Zhu S; Song K; He C
    Cell Commun Signal; 2022 Aug; 20(1):132. PubMed ID: 36042519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological properties of Saccharomyces cerevisiae from which hexokinase II has been deleted.
    Diderich JA; Raamsdonk LM; Kruckeberg AL; Berden JA; Van Dam K
    Appl Environ Microbiol; 2001 Apr; 67(4):1587-93. PubMed ID: 11282609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.